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Abstract
 .It was recently reported that co-expression of the proa1 III chain of human type III procollagen with the subunits of
human prolyl 4-hydroxylase in Pichia pastoris produces fully hydroxylated and properly folded recombinant type III
procollagen molecules Vuorela, A., Myllyharju, J., Nissi, R., Pihlajaniemi, T., Kivirikko, K.I., 1997. Assembly of human prolyl
4-hydroxylase and type III collagen in the yeast Pichia pastoris: formation of a stable enzyme tetramer requires coexpression
.with collagen and assembly of a stable collagen requires coexpression with prolyl 4-hydroxylase. EMBO J. 16, 6702]6712 .
These properly folded molecules accumulated inside the yeast cell, however, only ;10% were found in the culture medium.
 .We report here that replacement of the authentic signal sequence of the human proa1 III with the Saccharomyces cere¨isiae
a mating factor prepro sequence led only to a minor increase in the amount secreted. Immunoelectron microscopy studies
indicated that the procollagen molecules accumulate in specific membranous vesicular compartments that are closely
 .associated with the nuclear membrane. Prolyl 4-hydroxylase, an endoplasmic reticulum ER lumenal enzyme, was found to be
 .located in the same compartments. Non-helical proa1 III chains produced by expression without recombinant prolyl
4-hydroxylase likewise accumulated within these compartments. The data indicate that properly folded recombinant procolla-
gen molecules accumulate within the ER and do not proceed further in the secretory pathway. This may be related to the
large size of the procollagen molecule. Q 2000 Elsevier Science B.V.rInternational Society of Matrix Biology. All rights
reserved.
Keywords: Pichia pastoris; Collagen; Procollagen; Prolyl 4-hydroxylase
 .Abbre¨iations: 4-PH, prolyl 4-hydroxylase; PDI, protein disulfide isomerase; proa1 III chain, proa1 chain of type III procollagen; a chain,
a chain produced from procollagen by cleavage of the propeptides; a-MF, a mating factor prepro sequence
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1. Introduction
The collagen superfamily consists of at least 19
proteins formally defined as collagens and more than
10 additional proteins with collagen-like domains. All
collagen molecules consist of three identical or non-
identical polypeptide chains, called a chains, that are
wrapped around each other into a characteristic triple
helix. Collagen types I, II, III, V and XI form extra-
cellular fibrils and are hence known as fibril-forming
collagens, while the others form supramolecular ag-
gregates of other kinds. The molecules of the fibril-
forming collagens are synthesized in the form of
procollagen molecules, which differ from the final
collagen molecules in that their proa chains have
propeptide extensions at both their N-terminal and
C-terminal ends for reviews on collagens, see Kielty
et al., 1993; Prockop and Kivirikko, 1995; Bateman et
.al., 1996 .
Most recombinant systems now available for the
production of proteins cannot be used as such for the
expression of recombinant collagens, as bacteria and
yeasts have no prolyl 4-hydroxylase activity and insect
cells have insufficient amounts of it Lamberg et al.,
.1996; Myllyharju et al., 1997 . This enzyme plays a
crucial role in the synthesis of all collagens, as 4-
hydroxyproline residues are essential for the forma-
tion of molecules with stable triple helices. The verte-
brate prolyl 4-hydroxylases are a b tetramers in2 2
which the b subunit is identical to the enzyme and
 . chaperone protein disulfide isomerase PDI for re-
views, see Kivirikko and Myllyharju, 1998; Kivirikko
.and Pihlajaniemi, 1998 .
It was recently reported that co-expression of the a
subunit of human prolyl 4-hydroxylase, the human
PDI polypeptide and the proa1 chain of human type
III procollagen in Pichia pastoris produced an active
recombinant prolyl 4-hydroxylase tetramer and
 .proa1 III chains in which the appropriate proline
residues were hydroxylated to 4-hydroxyproline
 .  .Vuorela et al., 1997 . The proa1 III chains were of
full length and properly disulfide-bonded and formed
w  .xproa1 III procollagen molecules with stable triple3
 .helices Vuorela et al., 1997 , but they accumulated
predominantly inside the yeast cell, only approxi-
mately 10% being found in the culture medium. This
finding is surprising, as triple-helical procollagen
molecules are rapidly secreted into the extracellular
space from various animal cells see Prockop et al.,
.1979; Kielty et al., 1993 . We therefore studied here
the intracellular site of accumulation of the recombi-
nant type III procollagen molecules in P. pastoris, and
whether replacement of the signal peptide of the
 .proa1 III chain with the Saccharomyces cere¨isiae a
 .mating factor aMF prepro sequence will increase
the amount of procollagen secreted.
2. Results
2.1. Analysis of the cellular morphology of the
recombinant P. pastoris strains
The cellular morphology of the methanol-induced
wild-type strain and the recombinant strains
 .arPDIa-MF, Proa1 III and arPDIa-MFrproa1-
 .III which express human prolyl 4-hydroxylase, hu-
man type III procollagen or both proteins, respec-
tively, were studied by electron microscopy using
KMnO -fixed cells.4
Analysis of the three recombinant strains revealed
the usual subcellular organelles such as nuclei, mito-
chondria, ER, vacuoles and peroxisomes, but additio-
nal membranous vesicular structures of irregular
shape were also seen in cells of all three recombinant
 .  .strains Fig. 1a . In the two strains, Proa1 III and
 .arPDIa-MFrproa1 III , expressing type III procol-
lagen without, or with, recombinant prolyl 4-hydroxyl-
ase, respectively, a few vesicles were considerably
 .larger and less electron-dense Fig. 1a . Some of the
membranes of this cytoplasmic tubular network struc-
ture were closely associated with the nuclear mem-
 .brane Fig. 1b . These structures were invariably
 .absent from the wild-type cells Fig. 1c , indicating
that specific structures developed in response to the
synthesis of the heterologous proteins in the recombi-
nant cells.
2.2. Localization of the recombinant human prolyl
4-hydroxylase and type III procollagen using
immunoelectron microscopy
In order to study where the triple-helical recombi-
nant human type III procollagen accumulates in the
P. pastoris cell, the locations of the recombinant prolyl
4-hydroxylase and type III procollagen were studied
by immunoelectron microscopy on ultrathin sections
of Unicryl-embedded cells. The sections were in-
cubated with polyclonal antibodies to the human PDI
polypeptide, the human prolyl 4-hydroxylase a sub-
unit or the N propeptide of human type III procolla-
gen followed by incubation with a gold-conjugated
secondary antibody.
The recombinant human prolyl 4-hydroxylase sub-
units expressed in P. pastoris were expected to be
located within the lumen of the ER, as judged by
their assembly into an enzyme tetramer that was
active both in vitro and inside the cells, the presence
of N-linked sugars in the polypeptides, and the cleav-
age of the signal peptide from the a subunit and the
 .aMF-PDI polypeptide Vuorela et al., 1997 . Im-
munolabeling of cells from the strain co-expressing
recombinant human prolyl 4-hydroxylase and type III
procollagen with antibodies to the prolyl 4-hydroxyl-
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 .  .  .Fig. 1. Analysis of the cellular morphology of the recombinant arPDI-aMFrproa1 III a,b and wild-type c P. pastoris strain. The cells
were cultured and induced with methanol as described in Section 4, fixed with KMnO , embedded in Epon 812 and analyzed using a Philips4
U .EM400 electron microscope. N, nucleus; P, peroxisome; M, mitochondrion; and L, lipid droplet. The bar represents 0.5 mm. The asterisk
 .  .  .in a and b indicates a large, less electron-dense vesicle. The arrows in b indicate the membranous tubular network structures.
ase a subunit and PDI polypeptide showed that the
enzyme subunits were specifically located in the lu-
men of the membranes of the proliferating cyto-
 .plasmic tubular network Fig. 2a,b . Labeling was also
seen in those regions of the tubular network that
were in close contact with the nuclear membrane, and
on the nuclear membrane at these contact sites. The
antibody to the PDI polypeptide showed an additional
 .extracellular labeling data not shown , which is in
accordance with the previous finding that despite the
presence of the ]KDEL or ]HDEL ER retention
signal, some of the aMF-PDI fusion peptide was
secreted into the culture medium Vuorela et al.,
.1997 . Similar labeling with the antibodies to the
prolyl 4-hydroxylase subunits was also seen in the
strain expressing recombinant human prolyl 4-
hydroxylase without type III procollagen data not
.shown .
Immunolabeling of cells from the strain co-ex-
pressing recombinant human prolyl 4-hydroxylase and
type III procollagen with an antibody to the N
propeptide of human type III procollagen showed
that the procollagen was also located in the lumen of
 .the membranes of the tubular networks Fig. 2c . In
order to confirm the co-localization of prolyl 4-
hydroxylase and type III procollagen in the same
cellular compartments, one side of each cell sections
was incubated with the antibody to the PDI polypep-
tide and a 15-nm gold particle-conjugated secondary
antibody, while the other side was incubated with the
antibody to the N propeptide of human type III
procollagen and a 5-nm gold particle-conjugated sec-
ondary antibody. These double-labeling experiments
showed that the PDI polypeptide and type III procol-
lagen are located in the same cellular compartments
 .Fig. 2d . Recombinant human type III procollagen
was localized to the lumen of the tubular network
structures also in the strain expressing only the type
 .III procollagen molecules data not shown . No label-
ing was observed in the extracellular matrix with this
antibody.
Control experiments showed that the immunolabel-
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 .  .  .Fig. 2. Cellular localization of the recombinant human prolyl 4-hydroxylase a subunit a , PDI polypeptide b , and type III procollagen c by
post-embedding immunogold-labeling of ultrathin sections. The recombinant human PDI and type III procollagen were co-labeled using 15
 .and 5 nm gold particle-conjugated secondary antibodies, respectively d . The bar represents 0.5 mm.
ing patterns that were seen were specific, as no label-
ing with any of the antibodies used was seen in the
cells from the GS200 strain, no labeling with the
antibody to the N propeptide of type III procollagen
was seen in the cells from the strain expressing only
recombinant human prolyl 4-hydroxylase, and no
labeling with the antibodies to the prolyl 4-hydroxyl-
ase a subunit and the PDI polypeptide was seen in
cells from the strain expressing only recombinant
human type III procollagen.
2.3. Secretion of recombinant human type III procollagen
with the S. cere¨isiae a mating factor prepro sequence in
P. pastoris
In order to study whether the use of the S. cere-
¨isiae aMF prepro sequence would enhance the se-
cretion of recombinant human type III procollagen, a
 .P. pastoris strain arPDIa-MFrproa1 III -aMF co-
expressing human prolyl 4-hydroxylase and type III
procollagen was generated. As reported previously,
the human PDI polypeptide had the aMF prepro
 .sequence Vuorela et al., 1997 , and in this new strain
 .the signal sequence of the human proa1 III chain
had likewise been replaced with the aMF prepro
 .sequence. The arPDIa-MFrproa1 III -aMF strain
was cultured in BMGY medium and recombinant
expression was induced in BMM medium by adding
methanol every 12 h to a final concentration of 0.5%.
The cells were harvested 72 h after induction, and
broken in a 5% glycerol, 1 mM EDTA and 50 mM
 .sodium phosphate buffer pH 7.4 . Aliquots of the
soluble fraction of the cell extracts from this strain
 .and the arPDIa-MFrproa1 III strain co-expressing
prolyl 4-hydroxylase and human type III procollagen
with its authentic signal sequence were analyzed by
SDS-PAGE under reducing conditions followed by
Western blotting with an antibody to the N propep-
tide of human type III procollagen. Bands corre-
 .sponding to the full-length proa1 III chains were
seen in the immunoblot in both strains, the chain
expressed with the aMF prepro sequence having a
slightly slower mobility, apparently due to the additio-
 .nal pro sequence Fig. 3a . Other aliquots of the cell
extracts were digested with pepsin for 2 h at 228C and
analyzed by SDS-PAGE followed by silver staining
 .  .Fig. 3b . Pepsin-resistant a1 III chains with an iden-
tical mobility were seen in the digested samples from
both strains, indicating that the chains formed triple-
helical molecules. Concentrated samples of the cul-
ture medium from the strains arPDIa-MFrproa1-
 .  .III and arPDIa-MFrproa1 III -aMF were ana-
lyzed by SDS-PAGE under reducing conditions fol-
lowed by Western blotting with an antibody to the N
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 .Fig. 3. Expression of human type III procollagen in P. Pastoris. a The GS200 control strain and the recombinant P. pastoris strains were
grown for 72 h in BMM containing 0.5% methanol. Aliquots containing 20 mg of total protein from the soluble fractions of the cell extracts
 .  .  .  .  .obtained from the GS200 lane 1 , arPDI-aMFrproa1 III lane 2 and arPDI-aMFrproa1 III -aMF lane 3 strains were analyzed by 5%
SDS-PAGE under reducing conditions followed by an immunoblot analysis using a polyclonal antibody to the N propeptide of human type III
 .  .procollagen. The position of the proa1 III chain is indicated by an arrow. b Aliquots containing approximately 150 mg of total protein from
 .  .  .  .the soluble fractions of the cell extracts obtained from the arPDI-aMFrproa1 III lane 1 and arPDI-aMFrproa1 III -aMF lane 2
 .strains were digested with pepsin and analyzed by 8% SDS-PAGE followed by silver staining. The position of the a1 III chain is indicated by
an arrow.
propeptide of type III procollagen. Only very faint
immunostained bands with identical mobilities were
seen in the concentrated medium samples from both
 .strains data not shown . The mobility of these bands
 .was identical to that of the intracellular proa1 III
chains expressed with the authentic signal peptide in
 .  .the strain arPDIa-MFrproa1 III data not shown .
Secretion of type III procollagen was also studied
by analyzing aliquots of the soluble fraction of the cell
extract and culture medium with a radioimmunoassay
for the trimeric N propeptide of human type III
procollagen. Most of the recombinant type III procol-
lagen with the aMF prepro sequence was again found
in the soluble fraction of the cell extract, but the
amount of type III procollagen with the aMF prepro
sequence in the soluble extracts was approximately
50% of that with the authentic signal peptide Table
.1 . The amount of type III procollagen secreted was
approximately 10% of the total amount expressed in
 .the arPDIa-MFrproa1 III strain and approxi-
 .mately 20% in the arPDIa-MFrproa1 III -aMF
 .strain Table 1 .
Thus, secretion of type III procollagen with the
aMF prepro sequence was only slightly improved
relative with its authentic signal sequence Vuorela et
.al., 1997 . In addition, the total expression level of
type III procollagen with the aMF prepro sequence
was lower than that with the authentic signal peptide.
3. Discussion
Type III procollagen molecules are assembled in
various cells synthesizing collagen within the lumen of
the endoplasmic reticulum, and their triple-helical
domain is a rigid, rod-like structure with a length of
approximately 300 nm and a diameter of approxi-
mately 1.5 nm. It is now well established that if triple
helix formation is prevented, the non-helical proa
chains accumulate within the lumen of the rough
endoplasmic reticulum see Prockop et al., 1979; Kielty
.et al., 1993 . Triple-helical procollagen molecules are
transported from the ER across the Golgi stacks
without ever leaving the lumen of the Golgi cisternae
 .Bonfanti et al., 1998 . During transport from the ER
to the Golgi, procollagen molecules are found within
tubular]saccular structures that have a length greater
than 300 nm, and they begin to aggregate laterally
Table 1
 .Expression and secretion of recombinant human type III procollagen in the P. pastoris strain arPDI-aMFrproa1 III and four
a .transformants of the strain arPDI-aMFrproa1 III -aMF
Strain Intracellular expression Secretion of type III procollagen as a
of type III procollagen percentage of the total amount of procollagen
 .ngr100 mg
 .arPDI-aMFrproa1 III 195"10 7"1
 .arPDI-aMFrproa1 III -aMF 1 80"5 18"2
 .arPDI-aMFrproa1 III -aMF 2 92"9 19"1
 .arPDI-aMFrproa1 III -aMF 3 110"10 17"4
 .arPDI-aMFrproa1 III -aMF 4 103"7 17"2
a Cells were cultured for 72 h in 25 ml of BMM containing 0.5% methanol. Soluble fractions of the cell extracts and samples of the culture
medium were analyzed with a radioimmunoassay for the trimeric N propeptide of human type III procollagen.
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within the cis-Golgi compartment Bonfanti et al.,
.1998 . Thus, supramolecular aggregates such as pro-
collagen do not appear to use the conventional vesi-
cle-mediated transport mechanism to traverse the
Golgi stacks. The cis cisterna evidently progresses
through the stack by going through successive matu-
ration stages, during which the procollagen aggregates
can be regarded as passive objects lying inside the
lumen while the cisternal membrane flows around
them in a retrograde direction Mironov et al., 1997;
.Bonfanti et al., 1998 . During this process the lumenal
environment changes gradually, leading to increased
condensation of the aggregates and resulting in the
formation of granules ready for secretion Bonfanti et
.al., 1998 .
The present data indicate that in the case of P.
pastoris cells synthesizing recombinant human type III
procollagen the secretory process is terminated at an
early stage, and properly folded procollagen molecules
 .Vuorela et al., 1997 accumulate in specific intracel-
lular membranous compartments. The a subunit of
prolyl 4-hydroxylase and the aMF-PDI polypeptide
were found to be located within these same compart-
ments. Prolyl 4-hydroxylase and the free PDI polypep-
tides have been shown by a variety of techniques to
reside within the lumen of the ER, and an active
system appears to exist for the transport of 2-oxo-
glutarate and ascorbate, two co-substrates required by
prolyl 4-hydroxylase, into the lumen of the ER through
 .the membranes see Kivirikko and Pihlajaniemi, 1998 .
The recombinant human prolyl 4-hydroxylase te-
tramer is apparently located within the lumen of the
ER in P. pastoris as well, as the enzyme is active and
 .hydroxylates the proa1 III chains inside the yeast
 .cell Vuorela et al., 1997 . The biochemical data indi-
cating that the signal peptide is cleaved from the a
subunit and the aMF-PDI polypeptide and that the a
subunit and the aMF propeptide contain N-linked
carbohydrate units agree with this location Vuorela
.et al., 1997 .
The authentic signal sequence of the human PDI
polypeptide has been found to be highly ineffective in
transporting the recombinant polypeptide in P. pas-
toris cells into the lumen of the ER, and a marked
increase in this transport was obtained when the
human signal sequence was replaced by the S. cere-
 .¨isiae aMF prepro sequence Vuorela et al., 1997 .
Interestingly, some of the aMF-PDI polypeptide was
also secreted from the P. pastoris cell despite the
presence of the ]KDEL or ]HDEL ER retention
 .signal, as found previously Vuorela et al., 1997 and
confirmed here. We, therefore, studied here whether
replacement of the human signal sequence of the
 .proa1 III chain by the aMF prepro sequence would
enhance the secretion of type III procollagen. Only a
minor degree of enhancement was found, however.
 .Proa1 III chains expressed without the prolyl 4-
hydroxylase subunits were found to accumulate within
the same tubular network structures as the type III
procollagen molecules produced by co-expression with
the enzyme. Molecules consisting of non-hydroxylated
proa chains have a T of only approximately 248Cm
see Prockop et al., 1979; Kivirikko and Pihlajaniemi,
.1998 , and thus non-hydroxylated chains cannot form
triple-helical molecules inside the yeast cell at 308C.
This argument is supported by the finding that the
two cysteine residues present at the very end of the
 .collagen domain of the proa1 III chain did not form
 .interchain disulfide bonds when the proa1 III chains
were expressed in P. pastoris without recombinant
prolyl 4-hydroxylase but did form the bonds when
 .expressed with the enzyme Vuorela et al., 1997 .
These interchain disulfide bonds are known to be
formed only after triple helix formation Bulleid et al.,
.1996 . As it is very well established that non-helical
proa chains accumulate within the lumen of the ER,
 .our localization of the non-hydroxylated proa1 III
chains and the hydroxylated procollagen molecules
within the same membranous compartment supports
the conclusion that the properly folded molecules
accumulate within the ER.
Our data thus indicate that properly folded procol-
lagen molecules accumulate within the ER and do not
proceed further in the secretory pathway. The ER]cis
Golgi transport step in the secretion of procollagen is
currently poorly understood. The procollagen
molecules that are formed within the ER are too long
to enter the COPII-coated vesicles involved in export
 .from this organelle see Bonfanti et al., 1998 , but one
possibility is that they might leave the ER inside
tubules protruding directly from the ER surface
 .Bonfanti et al., 1998 . The present data indicate that
the ER]cis Golgi step does not take place in the
synthesis of a procollagen in P. pastoris and raise the
possibility that this defect may be related to the large
size of the procollagen molecule.
4. Materials and methods
4.1. Plasmid construction
The sequence coding for the signal peptide of the
proa1 chain of human type III procollagen Tromp et
.al., 1989 was replaced with that coding for the S.
cere¨isiae aMF prepro sequence. The 59 end of the
cDNA, extending from the codon for the first amino
acid after the signal peptide cleavage site to the first
internal BamHI site with ClaI and NotI sites flanking
the 59 end, was synthesized by PCR, digested with
ClaI and BamHI and used first to replace the original
59 end. In order to remove 713 bp of 39-untranslated
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sequence of the cDNA, the 39 end extending from an
internal EcoRI site to the translation stop codon,
with NotI and XbaI sites following the stop codon,
was synthesized by PCR, digested with EcoRI and
XbaI and used to replace the original 39 end. This
construct was then digested with NotI, and the colla-
gen fragment was cloned into the NotI site of pPIC9
 .Invitrogen in frame with the aMF prepro sequence.
From this construct a BglII]NdeI fragment contain-
ing the AOX1 promoter and the aMF prepro se-
 .quence fused to the 59 end of the proa1 III chain
sequence up to an internal NdeI site was used to
replace the corresponding region in the previously
 .described pPICZ Bproa1 III expression plasmid to
 .generate pPICZ Bproa1 III a-MF.
4.2. Pichia pastoris strains and culture conditions
Generation of the strains arPDIa-MF expressing
 .human prolyl 4-hydroxylase, Proa1 III expressing the
proa1 chain of human type III procollagen, and
 .arPDIa-MFrproa1 III co-expressing prolyl 4-hy-
 .droxylase and the proa1 III chain, has been de-
 .scribed recently Vuorela et al., 1997 .
A recombinant strain co-expressing the proa1 chain
of human type III procollagen with the yeast aMF
prepro sequence and human prolyl 4-hydroxylase
w  . xarPDIa-MFrproa1 III -aMF was generated by in-
 .troducing PmeI-linearized pPICZ Bproa1 III a-MF
into the arPDIa-MF strain by electroporation as
described in the Pichia Expression Kit Manual, ver-
 .sion 3.0 Invitrogen . The methanol utilization pheno-
 .type of the arPDIa-MFrproa1 III -aMF strain was
confirmed to be methanol utilization plus.
The cells were cultured according to the methods
described in version 3.0 of the Pichia Expression Kit
 .Manual Invitrogen with slight modifications. They
were cultured in 25 ml of a buffered glycerol complex
 .medium BMGY, pH 6.0 containing 1 grl yeast
extract and 2 grl peptone. Expression of heterologous
genes was induced in a buffered minimal methanol
 .medium BMM, pH 6.0 by adding methanol every 12
or 24 h to a final concentration of 0.5%. Amino acids
were added up to 50 mgrl as required.
4.3. Analysis and purification of recombinant type III
procollagen
The cells were harvested after a 72-h methanol
induction at 308C, washed once and suspended in a
5% glycerol, 1 mM Pefabloc SC, 1 mM EDTA and 50
 .mM sodium phosphate buffer pH 7.4 . They were
then harvested and broken by vortexing with glass
beads. The cell extract was centrifuged at 10 000=g
for 20 min and the soluble fraction was collected. The
protein concentration in the soluble fraction was de-
 .termined using the Bio-Rad Protein Assay Bio-Rad .
Aliquots of the soluble fractions were analyzed by
SDS-PAGE under reducing conditions followed by
Western blotting with a polyclonal antibody to the N
propeptide of human type III procollagen Orion Di-
.agnostica . Samples of the culture medium were pre-
cipitated with 66% ethanol, redissolved in 1% SDS
and analyzed by SDS-PAGE under reducing condi-
tions followed by Western blotting with the antibody
to the N propeptide of human type III procollagen.
Further aliquots of the soluble fractions and the cul-
ture medium were analyzed with a radioimmunoassay
for the trimeric N propeptide of human type III
 .procollagen Orion Diagnostica . Other aliquots were
 .digested with pepsin 150 mgrml for 2 h at 228C and
analyzed by SDS-PAGE under reducing conditions
followed by silver staining.
4.4. Electron microscopy
 .The wild-type, GS200, arPDIa-MF, Proa1 III and
 .arPDIa-MFrproa1 III P. pastoris strains were in-
duced as above and harvested 24 h after methanol
induction. For morphological studies cells were fixed
with KMnO , embedded in Epon812 Keizer et al.,4
.1992 and viewed on a Philips EM400 electron mi-
croscope. For immunoelectron microscopy the cells
were fixed with 3% formaldehyde in sodium cacody-
 .  .late buffer pH 7.2 and embedded in Unicryl JanK .
Ultrathin sections were blocked with 0.5% bovine
serum albumin in PBSrglycine for 10 min at 48C and
incubated with 1:1000 dilutions of polyclonal antibody
K38 to the human PDI polypeptide Veijola et al.,
.1996 or K17 to the human prolyl 4-hydroxylase a
 .subunit Veijola et al., 1996 , or a polyclonal antibody
to the N propeptide of human type III procollagen
 .Orion Diagnostica for 16 h at 48C. The sections
were then incubated with a 15-nm gold particle-
 .conjugated goat anti-rabbit IgG Amersham for 1 h
at room temperature and stained with 1% uranyl
acetate and 0.2% methylcellulose Slot and Geuze,
.1984 . In double-labeling experiments one side of the
section was incubated with the K38 antibody and the
15-nm gold particle-conjugated goat anti-rabbit IgG,
while the other side was incubated with the polyclonal
antibody to the N propeptide of human type III
procollagen and a 5-nm gold particle-conjugated goat
 .anti-rabbit IgG Amersham , followed by staining as
above.
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